Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor suppressor immune gene therapy to reverse immunotherapy resistance.
Chada S, Wiederhold D, Menander KB, Sellman B, Talbott M, Nemunaitis JJ, Ahn HM, Jung BK, Yun CO, Sobol RE. Chada S, et al. Among authors: sobol re. Cancer Gene Ther. 2022 Jun;29(6):825-834. doi: 10.1038/s41417-021-00369-7. Epub 2021 Aug 5. Cancer Gene Ther. 2022. PMID: 34349241 Free PMC article.
The promised land.
Sobol RE, Scanlon KJ. Sobol RE, et al. Cancer Gene Ther. 2013 Dec;20(12):651. doi: 10.1038/cgt.2013.73. Cancer Gene Ther. 2013. PMID: 24346318 No abstract available.
Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck.
Nemunaitis J, Clayman G, Agarwala SS, Hrushesky W, Wells JR, Moore C, Hamm J, Yoo G, Baselga J, Murphy BA, Menander KA, Licato LL, Chada S, Gibbons RD, Olivier M, Hainaut P, Roth JA, Sobol RE, Goodwin WJ. Nemunaitis J, et al. Among authors: sobol re. Clin Cancer Res. 2009 Dec 15;15(24):7719-7725. doi: 10.1158/1078-0432.CCR-09-1044. Clin Cancer Res. 2009. PMID: 19996201
p53 therapy in a patient with Li-Fraumeni syndrome.
Senzer N, Nemunaitis J, Nemunaitis M, Lamont J, Gore M, Gabra H, Eeles R, Sodha N, Lynch FJ, Zumstein LA, Menander KB, Sobol RE, Chada S. Senzer N, et al. Among authors: sobol re. Mol Cancer Ther. 2007 May;6(5):1478-82. doi: 10.1158/1535-7163.MCT-07-0125. Epub 2007 May 4. Mol Cancer Ther. 2007. PMID: 17483435
Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine.
Shawler DL, Bartholomew RM, Garrett MA, Trauger RJ, Dorigo O, Van Beveren C, Marchese A, Ferre F, Duffy C, Carlo DJ, Sherman LA, Gold DP, Sobol RE. Shawler DL, et al. Among authors: sobol re. Clin Exp Immunol. 2002 Jul;129(1):99-106. doi: 10.1046/j.1365-2249.2002.01863.x. Clin Exp Immunol. 2002. PMID: 12100028 Free PMC article.
Human gene marker/therapy clinical protocols.
Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Brenner M, Oldfield E, Gansbacher B, Dunbar C, Walker RE, Schuening FG, Roth JA, Crystal RG, Welsh MJ, Culver K, Heslop HE, Simons J, Wilmott RW, Boucher RC, Siegler HF, Barranger JA, Karlsson S, Kohn D, Galpin JE, Raffel C, Hesdorffer C, Ilan J, Cassileth P, O'Shaughnessy J, Kun LE, Das TK, Wong-Staal F, Sobol RE, Haubrich R, Sznol M, Rubin J, Sorcher EJ, Rosenblatt J, Walker R, Brigham K, Vogelzang N, Hersh E, Eck SL. Rosenberg SA, et al. Among authors: sobol re. Hum Gene Ther. 2000 Apr 10;11(6):919-79. doi: 10.1089/10430340050015536. Hum Gene Ther. 2000. PMID: 10779168 No abstract available.
Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience.
Galanis E, Hersh EM, Stopeck AT, Gonzalez R, Burch P, Spier C, Akporiaye ET, Rinehart JJ, Edmonson J, Sobol RE, Forscher C, Sondak VK, Lewis BD, Unger EC, O'Driscoll M, Selk L, Rubin J. Galanis E, et al. Among authors: sobol re. J Clin Oncol. 1999 Oct;17(10):3313-23. doi: 10.1200/JCO.1999.17.10.3313. J Clin Oncol. 1999. PMID: 10506635 Clinical Trial.
51 results